Abstract
Monocytes are produced in the bone marrow and enter the blood. They generally leave the blood and enter a tissue, and then become macrophages. In healing wounds, circulating monocytes also enter the tissue and instead of becoming macrophages, can differentiate into fibroblast-like cells called fibrocytes. Fibrocytes are also present in the lesions associated with fibrosing diseases such as congestive heart failure, end stage kidney disease, and pulmonary fibrosis. We have found that culturing blood monocytes, or white blood cell preparations containing monocytes, in serum-free media permits some of the monocytes to differentiate into fibrocytes within 5 days, and that this differentiation is inhibited by the blood plasma protein serum amyloid P.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81
Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556–7562
Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R (2004) Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36:598–606
Gomperts BN, Strieter RM (2007) Fibrocytes in lung disease. J Leukoc Biol 82:449–456
Bellini A, Mattoli S (2007) The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 87:858–870
Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE (2007) Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen 15:113–121
Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE (2002) Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82:1183–1192
Pilling D, Buckley CD, Salmon M, Gomer RH (2003) Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol 17:5537–5546
Pilling D, Tucker NM, Gomer RH (2006) Aggregated IgG inhibits the differentiation of human fibrocytes. J Leukoc Biol 79:1242–1251
Pilling D, Fan T, Huang D, Kaul B, Gomer RH (2009) Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 4:e7475
Chesney J, Bacher M, Bender A, Bucala R (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA 94:6307–6312
Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160:419–425
Balmelli C, Ruggli N, McCullough K, Summerfield A (2005) Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J Leukoc Biol 77:923–933
Balmelli C, Alves MP, Steiner E, Zingg D, Peduto N, Ruggli N, Gerber H, McCullough K, Summerfield A (2007) Responsiveness of fibrocytes to toll-like receptor danger signals. Immunobiology 212:693–699
Yang L, Scott PG, Dodd C, Medina A, Jiao H, Shankowsky HA, Ghahary A, Tredget EE (2005) Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13:398–404
Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S (2003) Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171:380–389
Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304:81–90
Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM (2007) Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353:104–108
Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, Kaneko S (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 103:14098–14103
Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K, Gobel N, Talke Y, Schweda F, Mack M (2009) CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 106:17892–17897
Barth PJ, Koster H, Moosdorf R (2005) CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol Res Pract 201:301–304
Quan TE, Bucala R (2007) Culture and analysis of circulating fibrocytes. Methods Mol Med 135:423–434
Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D (2008) Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 83:1323–1333
Pilling D, Vakil V, Gomer RH (2009) Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. J Immunol Methods 351:62–70
Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438–446
Naik-Mathuria B, Pilling D, Crawford JR, Gay AN, Smith CW, Gomer RH, Olutoye OO (2008) Serum amyloid P inhibits dermal wound healing. Wound Repair Regen 16:266–273
Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, Pilling D, Gomer RH, Trial J, Frangogiannis NG, Entman ML (2006) Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 103:18284–18289
Pilling D, Gomer RH (2007) Regulatory pathways for fibrocyte differentiation. In: Bucala R (ed) Fibrocytes-new insights into tissue repair and systemic fibroses. World Scientific, Singapore, pp 37–60
Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, Travis EL, Gomer RH (2007) Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 179:4035–4044
Haudek SB, Trial J, Xia Y, Gupta D, Pilling D, Entman ML (2008) Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci USA 105:10179–10184
Cathcart ES, Wollheim FA, Cohen AS (1967) Plasma protein constituents of amyloid fibrils. J Immunol 99:376–385
Thompson AR, Enfield DL (1978) Human plasma P component: isolation and characterization. Biochemistry 17:4304–4311
Binette P, Binette M, Calkins E (1974) The isolation and identification of the P-component of normal human plasma proteins. Biochem J 143:253–254
Pepys MB, Dash AC (1977) Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet 1:1029–1031
Painter RH (1977) Evidence that C1t (amyloid P-component) is not a subcomponent of the first component of complement (C1). J Immunol 119:2203–2205
Pontet M, Engler R, Jayle MF (1978) One step preparation of both human C-reactive protein and CIt. FEBS Lett 88:172–175
de Beer FC, Pepys MB (1982) Isolation of human C-reactive protein and serum amyloid P component. J Immunol Methods 50:17–31
Gomer RH, Pilling D, Kauvar L, Ellsworth S, Pissani S, Real L, Ronkainen SD, Roife D, Ma F, Davis SC (2009) A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs. Wound Repair Regen 17:397–404
Hind CR, Collins PM, Renn D, Cook RB, Caspi D, Baltz ML, Pepys MB (1984) Binding specificity of serum amyloid P component for the pyruvate acetal of galactose. J Exp Med 159:1058–1069
Schwalbe RA, Dahlback B, Coe JE, Nelsestuen GL (1992) Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 31:4907–4915
de Beer FC, Baltz ML, Munn EA, Feinstein A, Taylor J, Bruton C, Clamp JR, Pepys MB (1982) Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology 45:55–70
Tillett WS, Francis T (1930) Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus. J Exp Med 52:561–571
Bach BA, Gewurz H, Osmand AP (1977) C-reative protein in the rabbit: isolation, characterization and binding affinity to phosphocholine. Immunochemistry 14:215–219
Kinoshita CM, Gewurz AT, Siegel JN, Ying SC, Hugli TE, Coe JE, Gupta RK, Huckman R, Gewurz H (1992) A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins. Protein Sci 1:700–709
Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, Hohenester E (1997) Amyloid P component. A critical review. Amyloid 4:274–295
Baltz ML, de Beer FC, Feinstein A, Pepys MB (1982) Calcium-dependent aggregation of human serum amyloid P component. Biochim Biophys Acta 701:229–236
Coker AR, Purvis A, Baker D, Pepys MB, Wood SP (2000) Molecular chaperone properties of serum amyloid P component. FEBS Lett 473:199–202
Hutchinson WL, Hohenester E, Pepys MB (2000) Human serum amyloid P component is a single uncomplexed pentamer in whole serum. Mol Med 6:482–493
Sorensen IJ, Andersen O, Nielsen EH, Svehag SE (1995) Native human serum amyloid P component is a single pentamer. Scand J Immunol 41:263–267
Crawford JR, Pilling D, Gomer RH (2010) Improved serum-free culture conditions for spleen-derived murine fibrocytes. J Immunol Methods 363(1):9–20
Acknowledgments
We would like to thank Nehemiah Cox and Jeff Crawford for critical reading of the manuscript. This work was supported by NIH grant HL083029.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pilling, D., Gomer, R.H. (2012). Differentiation of Circulating Monocytes into Fibroblast-Like Cells. In: Kolonin, M., Simmons, P. (eds) Stem Cell Mobilization. Methods in Molecular Biology, vol 904. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-943-3_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-943-3_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-942-6
Online ISBN: 978-1-61779-943-3
eBook Packages: Springer Protocols